SEC
|
Kelly John Alexander
|
Chief Financial Officer
|
|
-15K
|
$4.26
|
-$63.16K
|
|
SEC
|
Brown Melinda
|
N/A
|
|
+1.7K
|
$4.14
|
+$6.96K
|
|
SEC
|
Buehler Kevin
|
N/A
|
|
+5.1K
|
$4.16
|
+$21.12K
|
|
SEC
|
Brown Melinda
|
N/A
|
|
+1.8K
|
$4.75
|
+$8.74K
|
|
SEC
|
Buehler Kevin
|
N/A
|
|
+4.5K
|
$4.67
|
+$21.12K
|
|
SEC
|
Germano Geno J
|
N/A
|
|
+3.3K
|
$5.30
|
+$17.23K
|
|
SEC
|
Amoroso Michael
|
President and CEO
|
|
-964
|
$5.56
|
-$5.36K
|
|
SEC
|
Scimeca Dario
|
General Counsel and Secretary
|
|
-272
|
$4.91
|
-$1.34K
|
|
SEC
|
SMITH J. JEFFERSON
|
Chief Research Officer
|
|
-154
|
$4.91
|
-$756.14
|
|
SEC
|
Scimeca Dario
|
General Counsel and Secretary
|
|
-8.9K
|
$4.79
|
-$42.77K
|
|
SEC
|
SMITH J. JEFFERSON
|
Chief Research Officer
|
|
-10K
|
$4.79
|
-$49.27K
|
|
SEC
|
Amoroso Michael
|
President and CEO
|
|
-37K
|
$4.67
|
-$172.03K
|
|
SEC
|
Germano Geno J
|
N/A
|
|
+3.6K
|
$4.49
|
+$16.19K
|
|
SEC
|
Buehler Kevin
|
N/A
|
|
+4.3K
|
$4.88
|
+$21.08K
|
|
SEC
|
Kelly John Alexander
|
Chief Financial Officer
|
|
+2.1K
|
$4.75
|
+$10.04K
|
|
SEC
|
Brown Melinda
|
N/A
|
|
+3K
|
$4.55
|
+$13.72K
|
|
SEC
|
Kelly John Alexander
|
Chief Financial Officer
|
|
+3K
|
$6.76
|
+$20.28K
|
|
SEC
|
Amoroso Michael
|
President and CEO
|
|
+13K
|
$1.32
|
+$17.43K
|
|
SEC
|
Kelly John Alexander
|
Chief Financial Officer
|
|
+45K
|
$1.32
|
+$59.71K
|
|
SEC
|
Kelly John Alexander
|
Chief Financial Officer
|
|
+34K
|
$1.50
|
+$50.68K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+23K
|
$2.06
|
+$47.16K
|
|
SEC
|
Scimeca Dario
|
General Counsel and Secretary
|
|
+22K
|
$2.06
|
+$45.20K
|
|
SEC
|
List Alan
|
Chief Medical Officer
|
|
+18K
|
$2.10
|
+$38.35K
|
|
SEC
|
Kelly John Alexander
|
Chief Financial Officer
|
|
+17K
|
$3.08
|
+$51.37K
|
|
SEC
|
Barton Shane
|
VP & Corporate Controller
|
|
+2.7K
|
$5.70
|
+$15.16K
|
|
SEC
|
Kelly John Alexander
|
Chief Financial Officer
|
|
+3.7K
|
$5.51
|
+$20.45K
|
|
SEC
|
Scimeca Dario
|
General Counsel and Secretary
|
|
+11K
|
$4.98
|
+$52.65K
|
|
SEC
|
THOMSON DAVID S.
|
Chief Operating Officer
|
|
-30K
|
$11.52
|
-$345.60K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
-20K
|
$9.38
|
-$187.60K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+12K
|
$2.87
|
+$33.98K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+24K
|
$2.80
|
+$66.30K
|
|
SEC
|
KANE MATTHEW R.
|
President and CEO
|
|
+12K
|
$2.81
|
+$33.27K
|
|
SEC
|
KANE MATTHEW R.
|
President and CEO
|
|
+24K
|
$2.65
|
+$62.38K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+12K
|
$2.72
|
+$32.20K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+24K
|
$2.76
|
+$65.35K
|
|
SEC
|
KANE MATTHEW R.
|
President and CEO
|
|
+12K
|
$2.73
|
+$32.14K
|
|
SEC
|
KANE MATTHEW R.
|
President and CEO
|
|
+24K
|
$2.81
|
+$66.19K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+12K
|
$3.46
|
+$41.00K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+24K
|
$3.57
|
+$84.62K
|
|
SEC
|
KANE MATTHEW R.
|
President and CEO
|
|
+12K
|
$3.56
|
+$42.02K
|
|
SEC
|
KANE MATTHEW R.
|
President and CEO
|
|
+24K
|
$3.63
|
+$85.69K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+12K
|
$3.76
|
+$44.57K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+26K
|
$3.31
|
+$87.70K
|
|
SEC
|
KANE MATTHEW R.
|
President and CEO
|
|
+12K
|
$3.83
|
+$45.23K
|
|
SEC
|
KANE MATTHEW R.
|
President and CEO
|
|
+24K
|
$4.00
|
+$94.50K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+15K
|
$2.85
|
+$42.95K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+30K
|
$2.85
|
+$84.18K
|
|
SEC
|
KANE MATTHEW R.
|
President and CEO
|
|
+12K
|
$4.18
|
+$49.40K
|
|
SEC
|
KANE MATTHEW R.
|
President and CEO
|
|
+23K
|
$4.34
|
+$100.32K
|
|
SEC
|
THOMSON DAVID S.
|
Chief Operating Officer
|
|
-10K
|
$16.49
|
-$164.90K
|
|
SEC
|
ANSARI ABID
|
Chief Financial Officer
|
|
+8.8K
|
$1.20
|
+$10.54K
|
|
SEC
|
ANSARI ABID
|
Chief Financial Officer
|
|
+9.7K
|
$1.20
|
+$11.59K
|
|
SEC
|
Heery Christopher
|
Chief Medical Officer
|
|
+2.5K
|
$12.08
|
+$30.02K
|
|
SEC
|
JANTZ DEREK
|
Chief Scientific Officer
|
|
+13K
|
$1.18
|
+$15.55K
|
|
SEC
|
ANSARI ABID
|
Chief Financial Officer
|
|
+104K
|
$1.20
|
+$124.37K
|
|
SEC
|
THOMSON DAVID S.
|
Chief Development Officer
|
|
+117K
|
$1.18
|
+$138.19K
|
|
SEC
|
YAO TONY DUNG LING
|
N/A
|
|
+6.5K
|
$15.42
|
+$100.03K
|
|
SEC
|
FMR LLC
|
N/A
|
|
+3.7M
|
$16.00
|
+$59.81M
|
|
SEC
|
GOODMAN COREY S
|
N/A
|
|
+4.3M
|
$16.00
|
+$68.24M
|
|
SEC
|
Schinazi Raymond F
|
N/A
|
|
+93K
|
$13.60
|
+$1.27M
|
|
SEC
|
YAO TONY DUNG LING
|
N/A
|
|
+160K
|
$13.60
|
+$2.18M
|
|